850 related articles for article (PubMed ID: 30678377)
41. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
Hatfull GF; Dedrick RM; Schooley RT
Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
[TBL] [Abstract][Full Text] [Related]
42. Towards Inhaled Phage Therapy in Western Europe.
Wienhold SM; Lienau J; Witzenrath M
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
[TBL] [Abstract][Full Text] [Related]
43. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
Shariati A; Noei M; Chegini Z
J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
[TBL] [Abstract][Full Text] [Related]
44. Bacteriophages and Their Immunological Applications against Infectious Threats.
Criscuolo E; Spadini S; Lamanna J; Ferro M; Burioni R
J Immunol Res; 2017; 2017():3780697. PubMed ID: 28484722
[TBL] [Abstract][Full Text] [Related]
45. Current challenges and future opportunities of phage therapy.
Pires DP; Costa AR; Pinto G; Meneses L; Azeredo J
FEMS Microbiol Rev; 2020 Nov; 44(6):684-700. PubMed ID: 32472938
[TBL] [Abstract][Full Text] [Related]
46. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
Royer S; Morais AP; da Fonseca Batistão DW
Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
[TBL] [Abstract][Full Text] [Related]
47. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
Mirski T; Lidia M; Nakonieczna A; Gryko R
Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
[TBL] [Abstract][Full Text] [Related]
48. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.
Jariah ROA; Hakim MS
Rev Med Virol; 2019 Sep; 29(5):e2055. PubMed ID: 31145517
[TBL] [Abstract][Full Text] [Related]
49. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
Furfaro LL; Payne MS; Chang BJ
Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
[TBL] [Abstract][Full Text] [Related]
50. Bacteriophages: potential treatment for bacterial infections.
Duckworth DH; Gulig PA
BioDrugs; 2002; 16(1):57-62. PubMed ID: 11909002
[TBL] [Abstract][Full Text] [Related]
51. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
[TBL] [Abstract][Full Text] [Related]
52. Bacteriophages and its applications: an overview.
Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
[TBL] [Abstract][Full Text] [Related]
53. [Viruses for health: Bacteriophages].
Benech N; Chaffringeon L; Briot T; Kolenda C; Pirot F; Laurent F; Ferry T
Med Sci (Paris); 2022 Dec; 38(12):1043-1051. PubMed ID: 36692264
[TBL] [Abstract][Full Text] [Related]
54. Understanding and Exploiting Phage-Host Interactions.
Stone E; Campbell K; Grant I; McAuliffe O
Viruses; 2019 Jun; 11(6):. PubMed ID: 31216787
[TBL] [Abstract][Full Text] [Related]
55. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Maciejewska B; Olszak T; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
[TBL] [Abstract][Full Text] [Related]
56. [Phage lytic enzymes--new hope in battle against bacterial infections].
Niczyporuk JS; Bartoszcze M
Przegl Epidemiol; 2007; 61(4):713-21. PubMed ID: 18572503
[TBL] [Abstract][Full Text] [Related]
57. In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.
Casey E; van Sinderen D; Mahony J
Viruses; 2018 Mar; 10(4):. PubMed ID: 29601536
[TBL] [Abstract][Full Text] [Related]
58. A Wake-Up Call: We Need Phage Therapy Now.
Moelling K; Broecker F; Willy C
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
[TBL] [Abstract][Full Text] [Related]
59. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
Chanishvili N
Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
[TBL] [Abstract][Full Text] [Related]
60. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
Kakasis A; Panitsa G
Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
